CEI Van Outreach Screening Study
| Status: | Completed |
|---|---|
| Conditions: | Ocular, Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - 89 |
| Updated: | 4/17/2018 |
| Start Date: | January 2012 |
| End Date: | February 2, 2017 |
Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases
The primary goal of the trial is to show that optical coherence tomography (OCT) technology
can be used to effectively screen for diseases of the eye including glaucoma, macular
diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is
usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision.
Keratoconus is a disease that affects the cornea (clear surface covering the colored part of
the eye).
can be used to effectively screen for diseases of the eye including glaucoma, macular
diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is
usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision.
Keratoconus is a disease that affects the cornea (clear surface covering the colored part of
the eye).
The identification of many eye diseases would significantly benefit from earlier detection
than is available with typical eye exams. Optical coherence tomography (OCT) is an imaging
technology that can perform non-contact cross-sectional imaging of tissue structure in real
time. It is similar to ultrasound B-mode imaging, except that OCT measures the intensity of
reflected light rather than sound waves.
than is available with typical eye exams. Optical coherence tomography (OCT) is an imaging
technology that can perform non-contact cross-sectional imaging of tissue structure in real
time. It is similar to ultrasound B-mode imaging, except that OCT measures the intensity of
reflected light rather than sound waves.
Inclusion Criteria:
- Participant undergoing a screening examination at the Casey Eye Institute Outreach
Van.
- Participants must be between the ages of 18 and 89 years old.
Exclusion Criteria:
- Inability to give informed consent.
- Inability to maintain stable fixation for OCT imaging
We found this trial at
1
site
Click here to add this to my saved trials
